They also issued emergency use authorization (EUA) for use of the reformulated jabs in children aged 6 months to 11 years.2

The updated mRNA injections contain a single modified RNA said to correspond to the Omicron variant XBB.1.5., which was the dominant variant in the U.S. for most of 2023, but which has since been replaced by other variants.

According to authorities, however, this strain is different enough from the strains in any of the previous shots to recommend everyone take it, regardless of your previous COVID jab history.3

Fortunately, most Americans are not falling for the same lies this time around. Most have realized that the shots are ineffective and can cause all sorts of health problems, including heart damage and immune system deregulation. Most people are also tired of the never-ending boosters.

In all, high-risk individuals (such as the elderly and/or immunocompromised of all ages) who were recommended to get additional doses will have received as many as six mRNA injections at this point — a three-dose primary series in 2021,4 two boosters to the primary series during 2021/2022,5 and one bivalent booster in the fall of 2022.6 The latest reformulation for XBB.1.5 will be the seventh in just three years.7

Non-mRNA Shot Authorized as Public Rejects mRNA

Uptake of the new monovalent shots has been disappointing, however. As of October 12, 2023, only 7 million Americans had rolled up their sleeves. For comparison, by October 12, 2022, more than 18 million had received the bivalent booster released that September, and by May 2023, 17% of the population — 56.5 million people — had received it.8